Add like
Add dislike
Add to saved papers

Association between HIF1α 1772 C/T Polymorphism and Breast Cancer Susceptibility: A Systematic Review.

Studies have reached conflicting conclusions about the association of the 1772 C/T polymorphism in the hypoxia-inducible factor 1α (HIF1α) gene with breast cancer risk. To address this, we performed a meta-analysis of relevant studies in the included literature. Data were collected from the electronic databases PubMed and EMBase. The association was assessed by determination of the odds ratio (OR) and the corresponding 95% confidence interval (95% CI). A total of seven articles involving 2343 cases and 2246 controls were analyzed in our meta-analysis. Overall, we found no significant association between the HIF1α C1772T polymorphism and breast cancer (TT vs. CC: OR = 1.33, 95% CI = 0.49-3.63; CT vs. CC: OR = 1.07, 95% CI = 0.90-1.27; dominant model: OR = 1.10, 95% CI = 0.93-1.30; recessive model: OR = 1.32, 95% CI = 0.50-3.49). In stratified analysis by ethnic group, a statistically significant association was observed in Asians. Our findings demonstrated that the 1772 C/T polymorphism in the HIF1α gene might be a risk factor for the development of breast cancer in Asians.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app